Myles A. Brown is an American oncologist who studies connections between hormones, breast cancer, and prostate cancer,[1] particularly focusing on the role of estrogen receptors.[2] He is Emil Frei III Professor of Medicine in the Harvard Medical School,[3] and director of the Center for Functional Cancer Epigenetics in the Dana–Farber Cancer Institute.[1]

Brown was elected to the National Academy of Sciences in 2016,[1] the American Academy of Arts and Sciences in 2017,[4] and the National Academy of Medicine in 2020.[5]

References

  1. 1 2 3 "Myles A. Brown", Member directory, National Academy of Sciences, retrieved 2021-05-09
  2. ↑ Azar, Beth (July 2018), "Profile of Myles Brown", Proceedings of the National Academy of Sciences, 115 (32): 8054–8056, doi:10.1073/pnas.1810395115, PMC 6094136, PMID 30038006
  3. ↑ Myles Brown, MD, Dana–Farber Cancer Institute, retrieved 2021-05-09
  4. ↑ "Dr. Myles A. Brown", Member directory, American Academy of Arts and Sciences, retrieved 2021-05-09
  5. ↑ National Academy of Medicine Elects 100 New Members, National Academy of Medicine, 19 October 2020, retrieved 2021-05-09

Myles A. Brown publications indexed by Google Scholar



This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.